Ancora Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Ancora Advisors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$24.1K	–	1996
2023 Q1	$24.1K	Hold	1,000	–	–	﹤0.01%	1088
2022 Q4	$11K	Hold	1,000	–	–	﹤0.01%	1319
2022 Q3	$4K	Hold	1,000	–	–	﹤0.01%	1711
2022 Q2	$4K	Buy	+1,000	New	+$4.74K	﹤0.01%	1828

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ancora Advisors's PRVB Position: Q2 2023 in Review

Ancora Advisors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 1,000 shares — an estimated $24.1K sold.

Ancora Advisors first reported a position in PRVB in Q2 2022 and held it in 4 quarters. The position peaked at $24.1K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Ancora Advisors reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ancora Advisors sold 1,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $24.1K.
Ancora Advisors first reported a position in Provention Bio, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
Ancora Advisors's Provention Bio, Inc. Common Stock position peaked at $24.1K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.